More pharma companies raided in EU

European Union antitrust regulators said they made surprise raids on the offices of drugmakers in several European nations Wednesday to seek evidence that they struck anticompetitive business deals or used a dominant market position to squeeze rivals. Release | Report

Suggested Articles

After years of having first-line liver cancer market to itself, Bayer’s Nexavar is getting major competition from Roche's Tecentriq.

Most of the recent enthusiasm around AbbVie’s new drugs has centered on Skyrizi and Rinvoq, but elagolix wants a piece of the spotlight, too.

During David Loew's tenure, Sanofi Pasteur bought Protein Sciences, whose recombinant technology is being applied to a COVID-19 vaccine.